Oracle Introduces Oracle Health Sciences Clinical Development Center Version 3.1
Oracle
today announced the availability of Oracle Health Sciences Clinical Development Center 3.1, a centralized solution for integrating, managing, and analyzing clinical trial information.
The release provides new integration, increased automation, and expanded data standardization to accelerate processing of clinical trial data from multiple sources in a variety of formats and increase user productivity from capture through submission.
Oracle Health Sciences Clinical Development Center 3.1 features automated data load and new execution triggers to increase the timeliness and accuracy of data analysis. The system now automatically reruns routines and programs against the most recent data and notifies users of data and study changes as they occur. The system can also be personalized to notify users of specific events that require their attention.
New governance capabilities allow for the creation of validated libraries to drive standardization, control and reuse of data models, macros, and programs across studies.
Version 3.1 also features a pre-built integration with Oracle Health Sciences InForm GTM electronic data capture (EDC) solution, as well as enhanced support for Medidata Rave clinical data management and EDC platform, automating the set up of Medidata Rave studies and data loading to save time and reduce potential for error. Oracle Health Sciences Clinical Development Center 3.1 now also supports the use of Interactive SAS for program development, and integrates with Oracle’s Siebel Clinical Trial Management System to help auto load study metadata.
The latest version also supports the management of data from studies in multiple languages.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
